The argument for pre-operative chemoradiation for localized, radiographically resectable pancreatic cancer
- 30 April 2006
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Gastroenterology
- Vol. 20 (2) , 365-382
- https://doi.org/10.1016/j.bpg.2005.11.005
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Vascular endothelial growth factor receptor‐1 promotes migration and invasion in pancreatic carcinoma cell linesCancer, 2005
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic TherapyScience, 2005
- Pancreaticoduodenectomy with vascular resection: margin status and survival durationJournal of Gastrointestinal Surgery, 2004
- Neoadjuvant therapy for resectable pancreatic cancerSurgical Oncology Clinics of North America, 2004
- A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic CancerNew England Journal of Medicine, 2004
- Phase II Study of Oral Capecitabine in Patients With Advanced or Metastatic Pancreatic CancerJournal of Clinical Oncology, 2002
- Combining gemcitabine with radiation in pancreatic cancer: Understanding important variables influencing the therapeutic indexSeminars in Oncology, 2001
- Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreas: Treatment Variables and Survival DurationAnnals of Surgical Oncology, 2001
- Resection of locally advanced pancreatic cancer after downstaging with continuous-infusion 5-fluorouracil, mitomycin-C, leucovorin, and dipyridamoleJournal of Gastrointestinal Surgery, 1998
- Treatment perspectives in locally advanced unresectable pancreatic cancerBritish Journal of Surgery, 1991